- page 68

Particle Accelerators Create Potential Cancer Treatment in Lansing

A Lansing company called Niowave has begun producing actinium-225, a silvery metal isotope that barely exists on Earth, with a superconducting linear accelerator. The reason? This isotope is a promising cancer treatment; however, researchers don’t know its full potential due to the absence of clinical trials.  Niowave has secured a $5 million deal with Fusion..

Read more